Home / Featured Companies / Biogen Historical Data

Biogen (BIIB) Financials

Biogen (BIIB) Historical Financial Statements and Key Metrics for 1985 - 2021

Full Biogen financials for 1985 - 2021 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Biogen Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2021-Mar-31 2,694 2,216 (82.3 %) 940 (34.9 %) 410 (15.2 %) 1,087 2.69
2020-Dec-31 2,853 2,362 (82.8 %) -486 (-17.0 %) 358 (12.5 %) -396 2.28
2020-Sep-30 3,376 2,927 (86.7 %) 1,057 (31.3 %) 702 (20.8 %) 1,191 4.46
2020-Jun-30 3,682 3,270 (88.8 %) 1,984 (53.9 %) 1,542 (41.9 %) 2,097 9.59
2020-Mar-31 3,534 3,080 (87.1 %) 1,890 (53.5 %) 1,399 (39.6 %) 2,010 8.08
2019-Dec-31 3,671 3,224 (87.8 %) 1,740 (47.4 %) 1,440 (39.2 %) 1,853 8.08
2019-Sep-30 3,600 3,170 (88.1 %) 1,731 (48.1 %) 1,546 (42.9 %) 2,061 8.39
Full historical income statements for 1985 - 2021 is included in the US Historical Financials dataset.

Biogen Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2021-Mar-31 23,855 13,192 7,647 10,682 2,538
2020-Dec-31 24,619 13,933 14,852 10,686 2,610
2020-Sep-30 24,934 14,190 8,780 10,744 3,580
2020-Jun-30 25,512 14,223 9,366 11,289 4,328
2020-Mar-31 26,119 13,582 5,962 12,537 3,860
2019-Dec-31 27,234 13,895 5,955 13,339 4,476
2019-Sep-30 27,484 13,492 5,954 13,992 4,437
Full historical balance sheet data for 1985 - 2021 is included in the US Historical Financials dataset.

Biogen Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2021-Mar-31 769 -65 -785 676
2020-Dec-31 -367 -166 -401 -468
2020-Sep-30 1,181 -52 -1,313 1,097
2020-Jun-30 1,948 -833 -1,313 1,844
2020-Mar-31 1,467 443 -2,245 1,206
2019-Dec-31 1,960 708 -2,116 1,695
2019-Sep-30 1,695 -366 -689 1,605
Full historical cash flow data for 1985 - 2021 is included in the US Historical Financials dataset.

Biogen Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2021-Mar-31 42,494 48,544 15.77 25.90 3.98
2020-Dec-31 38,419 51,940 13.47 26.84 3.60
2020-Sep-30 44,509 49,710 13.18 15.86 4.14
2020-Jun-30 42,969 48,007 11.67 6.97 3.81
2020-Mar-31 54,670 58,041 15.47 9.77 4.36
2019-Dec-31 52,759 55,800 14.37 9.16 3.96
2019-Sep-30 42,839 46,448 11.90 6.93 3.06
Full historical valuation and operating metrics for 1985 - 2021 are included in the US Historical Financials dataset.